HSR26-210: Patient Characteristics and Survival Outcomes in FLT3 Internal Tandem Duplication (ITD) vs. FLT3 Tyrosine Kinase Domain (TKD) Mutated AML: Insights from a Real-World Cohort
Journal of the National Comprehensive Cancer Network · 31.03.2026 · 24 (3.5)
DOI: 10.6004/jnccn.2025.7398 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the National Comprehensive Cancer Network, erschienen am 31.03.2026. Verfasst von Elizabeth Marrett und 5 weiteren Autor:innen. Beteiligte Einrichtung: 1Daiichi Sankyo, Inc., Basking Ridge, NJ.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- 1Daiichi Sankyo, Inc., Basking Ridge, NJ.
- 2Kredhera, LLC, Hampton, NJ.
Zitieren
APA
Marrett, E., Mavros, P., Xiong, Y., Zhou, S., Unni, S., & Fliss, A. (2026). HSR26-210: Patient Characteristics and Survival Outcomes in FLT3 Internal Tandem Duplication (ITD) vs. FLT3 Tyrosine Kinase Domain (TKD) Mutated AML: Insights from a Real-World Cohort. Journal of the National Comprehensive Cancer Network, 24(3.5). https://doi.org/10.6004/jnccn.2025.7398
Vancouver
Marrett E, Mavros P, Xiong Y, Zhou S, Unni S, Fliss A. HSR26-210: Patient Characteristics and Survival Outcomes in FLT3 Internal Tandem Duplication (ITD) vs. FLT3 Tyrosine Kinase Domain (TKD) Mutated AML: Insights from a Real-World Cohort. Journal of the National Comprehensive Cancer Network. 2026;24(3.5). doi:10.6004/jnccn.2025.7398
BibTeX
@article{Marrett2026,
author = {Marrett, Elizabeth and Mavros, Panagiotis and Xiong, Yan and Zhou, Summera and Unni, Sudhir and Fliss, Albert},
title = {HSR26-210: Patient Characteristics and Survival Outcomes in FLT3 Internal Tandem Duplication (ITD) vs. FLT3 Tyrosine Kinase Domain (TKD) Mutated AML: Insights from a Real-World Cohort},
journal = {Journal of the National Comprehensive Cancer Network},
year = {2026},
volume = {24},
number = {3.5},
doi = {10.6004/jnccn.2025.7398}
}
EUVIMED